Allworth Financial LP Genmab A/S Transaction History
Allworth Financial LP
- $20.2 Billion
- Q2 2025
A detailed history of Allworth Financial LP transactions in Genmab A/S stock. As of the latest transaction made, Allworth Financial LP holds 983 shares of GMAB stock, worth $28,349. This represents 0.0% of its overall portfolio holdings.
Number of Shares
983
Previous 724
35.77%
Holding current value
$28,349
Previous $14,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding GMAB
# of Institutions
256Shares Held
65.7MCall Options Held
32.5KPut Options Held
55K-
Alliancebernstein L.P. New York, NY10.7MShares$308 Million0.08% of portfolio
-
Orbis Allan Gray LTD Hamilton, D07.92MShares$228 Million1.07% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$147 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.57MShares$103 Million0.01% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.45MShares$99.6 Million0.05% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $19B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...